Published in Brain Behav Immun on December 20, 2012
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience (2013) 1.55
The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol (2015) 1.28
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med (2016) 1.26
Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry (2013) 1.18
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci (2014) 1.15
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry (2016) 1.01
Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine (2015) 0.94
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. JAMA Psychiatry (2016) 0.93
Association between mental disorders and subsequent adult onset asthma. J Psychiatr Res (2014) 0.93
Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor. Bioorg Med Chem (2015) 0.91
Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases. Mol Cells (2014) 0.90
Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav Immun (2013) 0.89
Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J Neuroinflammation (2013) 0.87
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol (2013) 0.87
High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation. Neuropsychopharmacology (2015) 0.86
NLRP3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice via Neuroinflammation. Int J Neuropsychopharmacol (2015) 0.85
Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma. Mediators Inflamm (2015) 0.85
Peripheral and Central Mechanisms of Stress Resilience. Neurobiol Stress (2015) 0.84
Inflammatory cytokine-associated depression. Brain Res (2014) 0.84
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond. Neuropsychopharmacology (2016) 0.83
Social defeat promotes a reactive endothelium in a brain region-dependent manner with increased expression of key adhesion molecules, selectins and chemokines associated with the recruitment of myeloid cells to the brain. Neuroscience (2014) 0.83
Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder. Med Sci Monit (2015) 0.82
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists. ACS Med Chem Lett (2013) 0.81
Depression and posttraumatic stress disorder among women with vulvodynia: evidence from the population-based woman to woman health study. J Womens Health (Larchmt) (2015) 0.81
Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms. Clin Rheumatol (2014) 0.81
Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) (2015) 0.80
Neuroinflammation: the devil is in the details. J Neurochem (2016) 0.80
Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience. Neuropsychopharmacology (2016) 0.80
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry (2016) 0.80
Genetic Contributions of Inflammation to Depression. Neuropsychopharmacology (2016) 0.79
A potential role for the acid-sensing T cell death associated gene-8 (TDAG8) receptor in depression-like behavior. Physiol Behav (2015) 0.79
P2X ion channel receptors and inflammation. Purinergic Signal (2016) 0.79
Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety. Brain Behav Immun (2017) 0.79
Adolescent Alcohol Exposure Persistently Impacts Adult Neurobiology and Behavior. Pharmacol Rev (2016) 0.78
Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites. Brain Sci (2016) 0.78
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology (2016) 0.78
Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms. Mediators Inflamm (2016) 0.77
Risk and Resilience: Animal Models Shed Light on the Pivotal Role of Inflammation in Individual Differences in Stress-Induced Depression. Biol Psychiatry (2015) 0.77
Cross-species evidence for the role of interleukin-33 in depression risk. J Abnorm Psychol (2016) 0.77
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness. Neural Plast (2016) 0.77
Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. J Neuroinflammation (2017) 0.77
Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. Alcohol (2016) 0.76
Neurobiological advances identify novel antidepressant targets. World Psychiatry (2013) 0.76
Molecular serum signature of treatment resistant depression. Psychopharmacology (Berl) (2016) 0.76
Effects of hydrogen-rich water on depressive-like behavior in mice. Sci Rep (2016) 0.76
A role for histone acetylation mechanisms in adolescent alcohol exposure-induced deficits in hippocampal brain-derived neurotrophic factor expression and neurogenesis markers in adulthood. Brain Struct Funct (2016) 0.76
Inflammasome Activation in Major Depressive Disorder: A Pivotal Linkage Between Psychological Stress, Purinergic Signaling, and the Kynurenine Pathway. Biol Psychiatry (2016) 0.75
Depressive-like behavior, its sensitization, social buffering, and altered cytokine responses in rhesus macaques moved from outdoor social groups to indoor housing. Soc Neurosci (2016) 0.75
Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy. Cytokine (2017) 0.75
Transcriptomic Modification in the Cerebral Cortex following Noninvasive Brain Stimulation: RNA-Sequencing Approach. Neural Plast (2016) 0.75
NLRP3 inflammasome: common nexus between depression and cardiovascular diseases. Nat Rev Cardiol (2017) 0.75
Ionizing Radiation-Induced Immune and Inflammatory Reactions in the Brain. Front Immunol (2017) 0.75
Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep (2017) 0.75
Microglia: An Interface between the Loss of Neuroplasticity and Depression. Front Cell Neurosci (2017) 0.75
Fibromyalgia and microglial TNF-α: Translational research using human blood induced microglia-like cells. Sci Rep (2017) 0.75
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence. Mol Neurobiol (2016) 0.75
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell (2002) 20.11
The inflammasomes. Cell (2010) 19.37
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol (1999) 16.86
How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev (2000) 15.16
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 11.24
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60
The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol (2008) 10.39
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol (2009) 9.24
Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry (2000) 9.02
Neurobiology of depression. Neuron (2002) 8.56
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med (2011) 8.00
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med (2009) 7.06
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
The effects of stressful life events on depression. Annu Rev Psychol (1997) 5.98
The P2X7 receptor: a key player in IL-1 processing and release. J Immunol (2006) 5.35
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol (2003) 4.08
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol (2009) 3.85
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci (2001) 3.55
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (1987) 3.45
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience (1985) 3.27
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
A Swedish national twin study of lifetime major depression. Am J Psychiatry (2006) 3.06
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res (1990) 2.96
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev (1999) 2.77
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science (1987) 2.69
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med (1997) 2.52
Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol (2001) 2.50
Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med (2009) 2.45
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Sickness behavior as a new target for drug development. Trends Pharmacol Sci (1992) 2.42
A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry (2007) 2.38
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (1995) 2.35
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry (2007) 2.34
Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med (2011) 2.30
Molecular mechanisms involved in inflammasome activation. Trends Cell Biol (2009) 2.29
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A (2010) 2.17
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand (2001) 1.80
Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci (1998) 1.78
A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology (2007) 1.77
The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci (1998) 1.74
NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol (2010) 1.73
TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry (2006) 1.67
Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol (2002) 1.67
Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest (1989) 1.61
Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett (1995) 1.60
Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2006) 1.46
Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol (2008) 1.46
Fever: causes and consequences. Neurosci Biobehav Rev (1993) 1.45
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res (2003) 1.42
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet (2006) 1.42
Increase in interleukin-1beta in late-life depression. Am J Psychiatry (2005) 1.40
Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol (1993) 1.34
Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress (2000) 1.31
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.31
Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology (2011) 1.31
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology (1994) 1.31
Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci (2009) 1.30
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry (1993) 1.29
Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1β and TNF: implications for neuropathic pain. J Neurosci (2011) 1.27
Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. Eur J Intern Med (2010) 1.27
Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res (1988) 1.26
Depression in rheumatoid arthritis--underscoring the problem. Rheumatology (Oxford) (2006) 1.26
The burden of disease for treatment-resistant depression. J Clin Psychiatry (2001) 1.24
Psychoneuroimmunology. The interface between behavior, brain, and immunity. Am Psychol (1994) 1.24
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology (2010) 1.22
The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology (1999) 1.21
Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology (Oxford) (2008) 1.20
Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry (2011) 1.19
The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology (2002) 1.14
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology (2012) 1.13
Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res (1995) 1.13
NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy (2011) 1.13
Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol (2005) 1.13
Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci (2008) 1.12
Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J Neurochem (2011) 1.10
Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behav Immun (2009) 1.08
Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry (2006) 1.08
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett (2009) 1.07
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav Brain Res (2008) 1.06
Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res (1991) 1.04
Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun (1995) 1.03
NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One (2012) 1.01
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (2010) 10.97
The many faces of CREB. Trends Neurosci (2005) 5.58
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci (2002) 5.17
Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology (2007) 4.38
Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry (2011) 3.62
A negative regulator of MAP kinase causes depressive behavior. Nat Med (2010) 3.52
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol (2007) 3.32
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med (2008) 3.15
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus (2006) 3.02
Preclinical models: status of basic research in depression. Biol Psychiatry (2002) 2.76
Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology (2003) 2.75
Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron (2003) 2.41
Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci (2004) 2.27
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci (2002) 2.21
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A (2010) 2.17
Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry (2008) 2.14
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry (2007) 2.01
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med (2012) 1.97
Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem (2004) 1.96
A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry (2006) 1.95
Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci (2003) 1.95
Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry (2007) 1.94
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci (2002) 1.89
Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron (2003) 1.84
Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res (2008) 1.84
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology (2010) 1.81
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry (2004) 1.77
Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry (2011) 1.77
Antidepressant actions of the exercise-regulated gene VGF. Nat Med (2007) 1.69
TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry (2006) 1.67
Antidepressants and neuroplasticity. Bipolar Disord (2002) 1.66
Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One (2011) 1.58
Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci (2002) 1.58
Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology (2003) 1.53
Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets (2007) 1.47
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A (2008) 1.46
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry (2013) 1.44
VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol (2007) 1.41
Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology (2006) 1.40
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med (2014) 1.39
GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology (2013) 1.37
Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci (2004) 1.34
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30
mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. Int J Neuropsychopharmacol (2011) 1.28
Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry (2013) 1.26
Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem (2006) 1.26
Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry (2004) 1.25
Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling. Neuropharmacology (2012) 1.21
Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology (2009) 1.21
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol (2012) 1.19
A double dissociation revealing bidirectional competition between striatum and hippocampus during learning. Proc Natl Acad Sci U S A (2008) 1.19
Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci (2005) 1.17
Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol Psychiatry (2008) 1.16
Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. Biol Psychiatry (2012) 1.14
Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacology (2005) 1.14
A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J Neurosci (2013) 1.12
Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. Eur J Neurosci (2008) 1.11
Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry (2003) 1.09
A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during endocytosis. Nat Cell Biol (2013) 1.08
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett (2009) 1.07
Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol Psychiatry (2010) 1.07
Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis (2012) 1.07
A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry (2008) 1.06
Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) 1.05
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs (2009) 1.05
Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol (2002) 1.04
Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J Neurosci (2005) 1.03
Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs (2007) 1.02
Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res (2011) 1.01
Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol (2011) 1.01
Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res (2008) 1.00
Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons. J Neurochem (2002) 1.00
Nestin promoter/enhancer directs transgene expression to precursors of adult generated periglomerular neurons. J Comp Neurol (2004) 0.99
Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proc Natl Acad Sci U S A (2012) 0.99
Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol Disord Drug Targets (2007) 0.99
Gene profiling the response to kainic acid induced seizures. Brain Res Mol Brain Res (2005) 0.99
Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology (2007) 0.96
Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res (2004) 0.96
Intracellular signaling pathways pave roads to recovery for mood disorders. Ann Med (2007) 0.95
New paradigms for treatment-resistant depression. Ann N Y Acad Sci (2013) 0.94
Affiliative behavior requires juvenile, but not adult neurogenesis. J Neurosci (2011) 0.94
Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol Psychiatry (2008) 0.94
Production of custom microarrays for neuroscience research. Methods (2005) 0.93
Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci (2012) 0.93
Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain. Neuropsychopharmacology (2005) 0.91
Electroconvulsive seizure promotes spine maturation in newborn dentate granule cells in adult rat. Dev Neurobiol (2012) 0.91
Acetylcholinesterase inhibitors activate septohippocampal GABAergic neurons via muscarinic but not nicotinic receptors. J Pharmacol Exp Ther (2003) 0.90
Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades. Drug Discov Today Ther Strateg (2008) 0.90
Effects of estradiol on learned helplessness and associated remodeling of hippocampal spine synapses in female rats. Biol Psychiatry (2010) 0.89
Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry (2003) 0.89
Molecular and behavioral interactions between central melanocortins and cocaine. J Pharmacol Exp Ther (2003) 0.89
Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest (2016) 0.85
Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci (2005) 0.85
Electroconvulsive seizure increases adult hippocampal angiogenesis in rats. Eur J Neurosci (2006) 0.85